Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD
Clinical trial NCT06192004 · TERMINATED
Trial details
- NCT number
- NCT06192004
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-05
- Primary completion
- 2025-04-30
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.